Whitepapers

Since 2020, the CDMO landscape has undergone significant changes. Dearth of fill/finish capacity in the US, exacerbated by COVID and vaccine production, caused market dislocation but also opportunity. With insights gathered through a blind, independent “voice of the customer” industry survey, discover what over 300 decision makers had to say about post-COVID trends and outsourcing plans. Among the intriguing responses captured in the survey – nearly 80% of respondents expressed they were open to, or actively looking for, new CRO/CDMO partners over the past 12 months.

Learn how Gibco™ Rapid Prototyping can help idenitfy the most feasible cell culture media for cGMP scale-up.

This session will address ways to help streamline media manufacturing, including rapid, small-scale non-cGMP media prototyping and proprietary media formulation outsourcing options.

Learn how Gibco™ Rapid Prototyping can accelerate your journey to cGMP

In this brochure, learn about the Eppendorf Centrifuge CR22N and CR30NX, the everyday centrifuges perfect for a wide range of applications. Read about unique features, technical specifications, common rotor options and more.

This application note describes production of a recombinant protein using a workflow for culturing and harvesting bacteria and purifying proteins. The Eppendorf Centrifuge CR22N or CR30NX is used in combination with the Innova S44i Shaker for a high yield of functional recombinant protein.

This white paper introduces a method for reducing harvesting time of yeast, bacteria, or cell cultures by up to 32% using the Eppendorf Centrifuge CR22N or CR30NX with unique triangular 1.5 L bottles.

This white paper highlights Pharma’s data integrity challenge and its impact on manufacturing, and proposes solutions for Pharma’s successful digital transformation journey.

In this industry brief, we examine key challenges that exist in the biopharma industry, particularly in the early phases of commercialization, and review ways organizations can address them.  

Moving a biopharmaceutical product from molecule-to-market is demanding in terms of expertise and capabilities needed throughout the development and manufacturing process. In this white paper, we explore the processes, operations, and customer-focused approach of Emergent CDMO's integrated internal teams, providing efficient organization alongside smooth and timely technology transfer and scale-up, from R&D to GMP manufacturing. Download our latest white paper to learn how partnering with an integrated CDMO can help create an efficient development services framework to achieve your drug substance and drug product manufacturing goals.

This article presents a detailed mapping of processes and data flow to identify the gaps associated to Data Integrity for GxP processes managed by computerized system and/or manually.

This application demonstrates the advantage of coupling LC-MS to a HPLC-UV system for highly sensitive (pg level) and selective quantitative analysis in cleaning validation.

Understand the role proper wiping technique plays in relaiable and consistent contamination control. Review the right way to quarterfold a wipe as well as the correct technique when wiping a surface to ensure contamination removal.